Jazz Pharmaceuticals (JAZZ) Capital Expenditures Growth (1y) (2011 - 2025)
Jazz Pharmaceuticals (JAZZ) Capital Expenditures Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 15.85 Bn | 14.01 Bn | 934.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6,115.66% |
| Sep 30, 2025 | 7,846.34% |
| Jun 30, 2025 | -91.90% |
| Dec 31, 2024 | 195.87% |
| Sep 30, 2024 | 1,033.19% |
| Jun 30, 2024 | 9.01% |
| Mar 31, 2024 | 7.01% |
| Dec 31, 2023 | -417.16% |
| Sep 30, 2023 | -95.08% |
| Jun 30, 2023 | 594.65% |
| Mar 31, 2023 | 490.40% |
| Dec 31, 2022 | 123.63% |
| Sep 30, 2022 | 10.50% |
| Jun 30, 2022 | 296.36% |
| Mar 31, 2022 | -523.57% |
| Dec 31, 2021 | -163.88% |
| Sep 30, 2021 | 181.55% |
| Jun 30, 2021 | -95.89% |
| Mar 31, 2021 | 68.91% |
| Dec 31, 2020 | 305.59% |